LANA SYKES: Open Payments
NPI 1083346233 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,388 in 74 payments from 24 companies in 2025. Trend: 2023 $588 · 2024 $838 · 2025 $1,388
Food & beverage: $1,383Education: $5
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $180 |
| Novo Nordisk Inc | 9 | $165 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 13 | $160 |
| Amgen Inc. | 12 | $153 |
| ViiV Healthcare Company | 5 | $127 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $91 |
| Exact Sciences Corporation | 4 | $84 |
| Eisai Inc. | 3 | $64 |
| Lilly USA, LLC | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
Products named: JARDIANCE, DOVATO, Wegovy, Kerendia, EVENITY, FASENRA, Leqembi, Cologuard Collection Kit.
Industry payments across WY — which companies pay providers there.
